Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Active, not recruiting · NCT00999804 · Registry updated 2025-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-03-12 | NCT00999804 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor Breast Care Center | 3 |
| GlaxoSmithKline | 294 |
| Translational Breast Cancer Research Consortium | 19 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine Lester and Sue Smith Breast Center | Houston | United States | 1 |
| Dana Farber Cancer Institute | Boston | United States | 1 |
| Duke University | Durham | United States | 91 |
| Indiana University | Indianapolis | United States | 160 |
| Johns Hopkins | Baltimore | United States | 7 |
| University of Alabama - Birmingham | Birmingham | United States | 6 |
| University of Chicago | Chicago | United States | 312 |
| Vanderbilt University Medical Center | Nashville | United States | 71 |